Articoli con mandati relativi all'accesso pubblico - Chang-Jiun WuUlteriori informazioni
Disponibili pubblicamente: 43
Comprehensive molecular portraits of human breast tumours
Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ...
Nature 490 (7418), 61-70, 2012
Mandati: US National Institutes of Health
Comprehensive molecular characterization of human colon and rectal cancer
Cancer Genome Atlas Network
Nature 487 (7407), 330, 2012
Mandati: US National Institutes of Health
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ...
Nature genetics 45 (10), 1113-1120, 2013
Mandati: US National Institutes of Health
The somatic genomic landscape of glioblastoma
CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ...
cell 155 (2), 462-477, 2013
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
Comprehensive genomic characterization of squamous cell lung cancers
Cancer Genome Atlas Research Network
Nature 489 (7417), 519, 2012
Mandati: US National Institutes of Health
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ...
Cell 161 (7), 1681-1696, 2015
Mandati: US National Institutes of Health, Cancer Research UK
Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer
A Kapoor, W Yao, H Ying, S Hua, A Liewen, Q Wang, Y Zhong, CJ Wu, ...
Cell 158 (1), 185-197, 2014
Mandati: US National Institutes of Health, National Institute for Health Research, UK …
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Z Ding, CJ Wu, GC Chu, Y Xiao, D Ho, J Zhang, SR Perry, ES Labrot, ...
Nature 470 (7333), 269-273, 2011
Mandati: US National Institutes of Health
Targeting YAP-dependent MDSC infiltration impairs tumor progression
G Wang, X Lu, P Dey, P Deng, CC Wu, S Jiang, Z Fang, K Zhao, ...
Cancer discovery 6 (1), 80-95, 2016
Mandati: US National Institutes of Health
Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer
Y Chen, J Kim, S Yang, H Wang, CJ Wu, H Sugimoto, VS LeBleu, ...
Cancer cell 39 (4), 548-565. e6, 2021
Mandati: US National Institutes of Health, Cancer Prevention Research Institute of …
Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases
Z Ding, CJ Wu, M Jaskelioff, E Ivanova, M Kost-Alimova, A Protopopov, ...
Cell 148 (5), 896-907, 2012
Mandati: US National Institutes of Health
Comprehensive T cell repertoire characterization of non-small cell lung cancer
A Reuben, J Zhang, SH Chiou, RM Gittelman, J Li, WC Lee, J Fujimoto, ...
Nature communications 11 (1), 603, 2020
Mandati: US Department of Defense, US National Institutes of Health, Howard Hughes …
TCR repertoire intratumor heterogeneity in localized lung adenocarcinomas: an association with predicted neoantigen heterogeneity and postsurgical recurrence
A Reuben, R Gittelman, J Gao, J Zhang, EC Yusko, CJ Wu, R Emerson, ...
Cancer discovery 7 (10), 1088-1097, 2017
Mandati: US Department of Defense, US National Institutes of Health
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer
MV Negrao, F Skoulidis, M Montesion, K Schulze, I Bara, V Shen, H Xu, ...
Journal for immunotherapy of cancer 9 (8), 2021
Mandati: US National Institutes of Health, Cancer Prevention Research Institute of …
Proinvasion metastasis drivers in early-stage melanoma are oncogenes
KL Scott, C Nogueira, TP Heffernan, R van Doorn, S Dhakal, JA Hanna, ...
Cancer cell 20 (1), 92-103, 2011
Mandati: US National Institutes of Health
Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer
Y Chen, S Yang, J Tavormina, D Tampe, M Zeisberg, H Wang, ...
Cancer cell 40 (8), 818-834. e9, 2022
Mandati: US National Institutes of Health
ILF2 is a regulator of RNA splicing and DNA damage response in 1q21-amplified multiple myeloma
M Marchesini, Y Ogoti, E Fiorini, AA Samur, L Nezi, M D'Anca, P Storti, ...
Cancer cell 32 (1), 88-100. e6, 2017
Mandati: US National Institutes of Health
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer
SK Subudhi, L Vence, H Zhao, J Blando, SS Yadav, Q Xiong, A Reuben, ...
Science translational medicine 12 (537), eaaz3577, 2020
Mandati: US National Institutes of Health
microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma
G Genovese, A Ergun, SA Shukla, B Campos, J Hanna, P Ghosh, ...
Cancer discovery 2 (8), 736-749, 2012
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
Tumor microenvironment remodeling enables bypass of oncogenic KRAS dependency in pancreatic cancer
P Hou, A Kapoor, Q Zhang, J Li, CJ Wu, J Li, Z Lan, M Tang, X Ma, ...
Cancer discovery 10 (7), 1058-1077, 2020
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software